Information Provided By:
Fly News Breaks for May 22, 2017
CNC
May 22, 2017 | 06:24 EDT
JPMorgan analyst Gary Taylor downgraded Centene to Neutral citing valuation with the shares up 32% since December 2016. The stock reflects very little probability of Senate Medicaid cuts or block grants, Taylor tells investors in a research note. He keeps a $75 price target for the shares.
News For CNC From the Last 2 Days
CNC
CNC
Apr 26, 2024 | 06:02 EDT
Reports Q1 revenue $40.41B, consensus $36.54B. "Centene's first quarter results demonstrate the strength of our diversified platform. We are pleased to raise full year 2024 guidance as we look to maximize the positive momentum being generated by our core businesses. We are executing against our strategic plans for growth and increasing access to affordable, high-quality healthcare for our members and the communities we serve," said Chief Executive Officer of Centene, Sarah M. London.
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.